Eris Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges that its trading window will be closed starting July 1, 2025, and will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2025. During this period, all designated persons (such as directors, key managerial personnel) and their immediate relatives are prohibited from trading in the company's shares. This is a standard compliance step under SEBI's insider trading regulations that companies follow ahead of quarterly earnings announcements.
This is a routine regulatory filing and not an operational event. However, it signals that Eris Lifesciences' Q1 FY26 results will be announced soon, which is when the stock could react based on the company's quarterly performance.